3M™ Tegaderm™ CHG I.V. Securement Dressing

DEVICE2 trials

Sponsors

University Hospital, Basel, Switzerland, Solventum US LLC

Conditions

Catheter-Related InfectionsCentral Venous Catheter Exit Site InfectionWound Contamination

Unknown Phase

Prospective Randomised Study for Use of CHG Dressing at Entry Site of EVD's to Reduce EVD-associated Infections

CompletedNCT02078830

University Hospital, Basel, SwitzerlandWound Contamination

Start: 2013-10-31End: 2017-03-31Updated: 2017-04-27

Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy

TerminatedNCT04906512

Solventum US LLCCatheter-Related Infections, Central Venous Catheter Exit Site Infection

Start: 2021-05-14End: 2022-03-31Updated: 2024-10-16

Related Papers

Long-term efficacy of chlorhexidine-containing cutaneous dressings on ventriculostomy-related infection: a 10-year before-and-after study.

2025-11-01

Effectiveness of a Chlorhexidine Dressing on Silver-coated External Ventricular Drain–associated Colonization and Infection: A Prospective Single-blinded Randomized Controlled Clinical Trial

Clinical Infectious Diseases2018-05-0226 citations